Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) Book/Monograph |
| Language: | English |
| Published: |
London
BioMed Central
05 February 2018
|
| DOI: | https://doi.org/10.1186/s12885-018-4032-3 |
| Online Access: | Resolving-System, kostenfrei, Volltext: http://dx.doi.org/https://doi.org/10.1186/s12885-018-4032-3 Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-242831 
|
| Author Notes: | Wolfgang Schuette, Peter Schirmacher, Wilfried E.E. Eberhardt, Manfred Dietel, Ute Zirrgiebel, Lars Muehlenhoff and Michael Thomas |
| Item Description: | Aus: BMC Cancer, 18 (2018), Nr. 135. pp. 1-10. ISSN 1471-2407 |
|---|---|
| Physical Description: | Online Resource |
| DOI: | https://doi.org/10.1186/s12885-018-4032-3 |